Bruce Elliot Strober, MD, PhD, FAAD
Yale University and Central Connecticut Dermatology
BIOGRAPHY
Dr. Bruce Strober earned both his medical and doctoral degrees from Columbia University in New York, New York. He completed his dermatology residency at the Department of Dermatology, New York University School of Medicine, also in New York. He is board-certified by the American Board of Dermatology and a Fellow of the American Academy of Dermatology. Dr. Strober's research interests focus on the study of both established and emerging therapies for inflammatory skin diseases, particularly interventions for challenging conditions such as psoriasis, atopic dermatitis, and hidradenitis suppurativa. He also explores novel aspects of these diseases and contributes to understanding their pathophysiology. Dr. Strober has served as a principal or sub-investigator in numerous multicenter clinical studies. He holds the position of Clinical Professor of Dermatology at Yale University School of Medicine and is the Editor-in-Chief of the Journal of Psoriasis and Psoriatic Arthritis. Previously, he was a Section Editor for the British Journal of Dermatology and has acted as an ad hoc reviewer for prestigious journals including Journal of the American Academy of Dermatology, JAMA Dermatology, British Journal of Dermatology, and The New England Journal of Medicine. He has authored over 250 book chapters and articles in peer-reviewed journals such as JAMA Dermatology, The New England Journal of Medicine, Journal of the American Academy of Dermatology, Journal of Investigative Dermatology, and Journal of the American Medical Association, among others. Dr. Strober has presented research data to the FDA, notably at advisory committee meetings for secukinumab, an innovative IL-17 inhibitor for psoriasis treatment. He currently serves as President on the Board of the International Psoriasis Council and as Scientific Co-Director of the CorEvitas Psoriasis Registry. His primary clinical practice centers on treating complex inflammatory skin conditions like psoriasis, atopic dermatitis, and hidradenitis suppurativa. Before co-founding Central Connecticut Dermatology, Dr. Strober was Professor and Chair of the Department of Dermatology at the University of Connecticut School of Medicine in Farmington, Connecticut.
SESSIONS
DISCLOSURES
AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Alumis – Consultant(Fees); Amgen – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant(Fees), Speaker(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); Bristol Myers Squibb – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Connect Biopharma LLC – Stockholder(Other Financial Benefit); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Dermavant Sciences, Inc. – Consultant(Fees), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Janssen Biotech – Speaker(Honoraria); Janssen-Ortho Inc. – Advisory Board(Honoraria), Consultant(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Fees); Mindera – Stockholder(Other Financial Benefit); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Consultant(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); Union Therapeutics – Consultant(Fees);